secwatch.observer — SEC 8-K summary
======================================

Issuer:     MERIT MEDICAL SYSTEMS INC (MMSI)
CIK:        0000856982
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0000856982-24-000094
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Merit Medical Q3 revenue up 7.8% to $339.8M, non-GAAP EPS $0.86, raises guidance
--------------------------------------------------------------------------------

- Revenue $339.8M (+7.8% YoY); GAAP EPS $0.48 (+8.0%); non-GAAP EPS $0.86 (+21.1%).
- Non-GAAP operating margin 19.2% vs 17.4% prior year; free cash flow $120M in 9 months (+116%).
- Acquired assets from EndoGastric Solutions (EsophyX Z+ for GERD treatment).
- Entered asset purchase for Cook Medical lead management portfolio; closing expected Nov 1, 2024.
- Raised full-year guidance; specifics not detailed in press release excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856982/000085698224000094/0000856982-24-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856982/000085698224000094/mmsi-20241030x8k.htm
  HTML page:      https://secwatch.observer/filing/0000856982-24-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer